Merck & Co., Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US58933Y1055
USD
117.09
-0.02 (-0.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
16,324.00
17,183.00
15,800.00
15,619.00
15,293.00
16,715.00
16,156.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
16,324.00
17,183.00
15,800.00
15,619.00
15,293.00
16,715.00
16,156.00
Raw Material Cost
4,817.00
4,194.00
3,847.00
3,885.00
3,528.00
4,441.00
4,293.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
411.00
327.00
305.00
313.00
328.00
330.00
310.00
Selling and Distribution Expenses
2,848.00
1,974.00
2,054.00
1,905.00
2,819.00
2,700.00
2,708.00
Other Expenses
208.80
322.50
323.50
280.60
372.40
497.90
257.60
Total Expenditure (Excl Depreciation)
10,164.00
9,720.00
9,441.00
8,909.00
10,399.00
12,450.00
9,887.00
Operating Profit (PBDIT) excl Other Income
6160
7463
6359
6710
4894
4265
6269
Other Income
238.00
320.00
-55.00
137.00
799.00
305.00
223.00
Operating Profit (PBDIT)
8,864.00
8,855.00
7,360.00
7,946.00
6,890.00
5,756.00
7,556.00
Interest
411.00
327.00
305.00
313.00
328.00
330.00
310.00
Exceptional Items
-2,567.00
-711.00
-1,000.00
-631.00
-1,195.00
-150.00
-176.00
Gross Profit (PBDT)
11,507.00
12,989.00
11,953.00
11,734.00
11,765.00
12,274.00
11,863.00
Depreciation
2,466.00
1,072.00
1,056.00
1,099.00
1,197.00
1,186.00
1,064.00
Profit Before Tax
3,420.00
6,745.00
4,999.00
5,903.00
4,170.00
4,090.00
6,006.00
Tax
458.00
958.00
571.00
818.00
425.00
929.00
545.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
2,963.00
5,785.00
4,427.00
5,079.00
3,743.00
3,157.00
5,455.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
2,963.00
5,785.00
4,427.00
5,079.00
3,743.00
3,157.00
5,455.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-1.00
2.00
1.00
6.00
2.00
4.00
6.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
2,962.00
5,787.00
4,428.00
5,085.00
3,745.00
3,161.00
5,461.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.5
0.5
0.5
0.5
0.5
0.5
0.5
Reserves
52,606.00
51,850.00
48,993.00
48,335.00
46,313.00
44,502.00
43,582.00
Earnings per share (EPS)
1.19
2.32
1.76
2.01
1.48
1.24
2.14
Diluted Earnings per share
1.19
2.32
1.76
2.01
1.48
1.24
2.14
Operating Profit Margin (Excl OI)
37.74%
43.43%
40.25%
42.96%
32.0%
25.52%
38.8%
Gross Profit Margin
36.06%
45.49%
38.32%
44.83%
35.09%
31.56%
43.76%
PAT Margin
18.15%
33.67%
28.02%
32.52%
24.48%
18.89%
33.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is -5.00% vs 8.75% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is -48.82% vs 30.69% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 1.07% vs 15.10% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is 25.69% vs 7.21% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

Compare Quarterly Results Of Merck & Co., Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
16,324.00
16,618.00
-294.00
-1.77%
Other Operating Income
0.00
0.00
0.00
Total Operating income
16,324.00
16,618.00
-294.00
-1.77%
Raw Material Cost
4,817.00
4,549.00
268.00
5.89%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
411.00
757.00
-346.00
-45.71%
Selling and Distribution Expenses
2,848.00
3,802.00
-954.00
-25.09%
Other Expenses
208.80
182.20
26.60
14.60%
Total Expenditure (Excl Depreciation)
10,164.00
10,930.00
-766.00
-7.01%
Operating Profit (PBDIT) excl Other Income
6,160.00
5,688.00
472.00
8.30%
Other Income
238.00
485.00
-247.00
-50.93%
Operating Profit (PBDIT)
8,864.00
8,160.00
704.00
8.63%
Interest
411.00
757.00
-346.00
-45.71%
Exceptional Items
-2,567.00
-2,748.00
181.00
6.59%
Gross Profit (PBDT)
11,507.00
12,069.00
-562.00
-4.66%
Depreciation
2,466.00
1,987.00
479.00
24.11%
Profit Before Tax
3,420.00
2,668.00
752.00
28.19%
Tax
458.00
853.00
-395.00
-46.31%
Provisions and contingencies
0
0
0.00
Profit After Tax
2,963.00
1,806.00
1,157.00
64.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
2,963.00
1,806.00
1,157.00
64.06%
Share in Profit of Associates
0
0
0.00
Minority Interest
-1.00
-1.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
2,962.00
1,805.00
1,157.00
64.10%
Equity Capital
0
0
0.00
Face Value
0.50
0.01
0.00
Reserves
52,606.00
-3,270.00
55,876.00
1,708.75%
Earnings per share (EPS)
1.19
1.02
0.17
16.67%
Diluted Earnings per share
1.19
1.02
0.17
16.67%
Operating Profit Margin (Excl OI)
37.74%
34.23%
0.00
3.51%
Gross Profit Margin
36.06%
28.01%
0.00
8.05%
PAT Margin
18.15%
10.87%
0.00
7.28%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,632.40 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -5.00% vs 8.75% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 6.74% vs 7.60% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 296.20 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -48.82% vs 30.69% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -20.91% vs 405.71% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 862.60 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 1.07% vs 15.10% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 41.62% vs 697.16% in Dec 2024

Quarterly - Interest
Interest 41.10 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 25.69% vs 7.21% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is 25.30% vs 5.81% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.74%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has fallen from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has improved from Dec 2024